What does the evidence say about Pea Protein Satiety Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Pea Protein Satiety Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - In particular, whey protein has demonstrated strong potential for postprandial glucose management, and more recent findings highlighted evidence for increased efficacy of whey protein when consumed before, rather than with a carbohydrate-rich meal. [Elbira A (2026); evidence level 2] - Given the strong interest yet limited evidence on plant-based protein, the present study compared the potential of pea protein consumed prior to carbohydrates, on postprandial glucose as well as satiety and blood pressure (BP). [Elbira A (2026); evidence level 2] - Results Both PP and PrePP significantly reduced postprandial glucose excursion (0.46 vs. [Elbira A (2026); evidence level 2] - Purpose Protein intake has shown benefits to mitigate postprandial hyperglycaemic excursions. [Elbira A (2026); evidence level 2] - A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. [Grant AD (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.